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Purpose: Genetic studies of OA have provided new etiological clues
since many of the discovered gene products orchestrate the process
of skeletal morphogenesis. The gene product deiodinase type-2 (D2)
of the OA susceptibility gene DIO2 discovered by our group is
responsible for catalyzing the conversion of intracellular inactive
thyroid (T4) to active thyroid hormone (T3). This subsequently
signals the terminal maturation of the growth plate chondrocytes
leading to cell hypertrophy, breakdown and mineralization of the
cartilage and eventually formation of bone. Such an upregulation of
thyroid signaling in articular cartilage should be considered detri-
mental to the joint tissues. In this respect, functional genomic studies
indicated upregulation of DIO2 gene expression and protein in
cartilage obtained from OA-affected joints as compared to healthy
joints. This could be due to the assessed consistent allelic imbalanced
expression of the DIO2 risk allele observed in joint tissues. Further-
more, we showed that carrier status of the DIO2 susceptibility SNPs
interacts with the association between aspects of hip joint geometry
and OA susceptibility. In the current study, we aim to investigate the
role of aberrant DIO2 gene expression during endochondral ossiﬁ-
cation by interfering with D2 protein function in an in vitro chon-
drogenesis model.
Methods: The ‘RAAK’ study contains human bone marrow derived
mesenchymal stem cells (BM-MSCs) which were isolated from OA
affected hip joints of subjects undergoing total hip arthroplasty.
BM-MSCs of 5 subjects were cultured as micromasses and differ-
entiated into cartilage particles. These micromass cultures were
maintained up to 49 days. The role of D2 on chondrogenesis was
investigated by either enhancing (excess T3 or lentiviral induced
DIO2 over-expression) or inhibiting (Iodopanoic Acid or IOP) D2
function. The effect on chondrogenesis was examined by quantiﬁ-
cation of micromass sizes, and immunohistochemistry (IHC) of
matrix components and RT-qPCR of relevant genes at different time
points.
Results: We show that interference with the thyroid hormone pathway
by either lentiviral DIO2 over-expression or addition of excess T3 in
a human (BM-MSC) in vitro chondrogenesis model, has a signiﬁcant
detrimental effect on the endochondral ossiﬁcation process as reﬂected
by the marked reduction in the capacity to deposit cartilage ECM
components (Aggrecan and COL2; Figure 1, panel A,B and C,D), delayed
chondrogenesis/maturation (reﬂected by COL10; Figure 1, panel E,F)
and induced expression of the enzymatic degradation proteins
ADAMTS5 and MMP13 and mineralization (ALPL). Furthermore, these
detrimental effects could be brought about by DIO2 over-expression
alone. In contrast, adding an inhibitor of deiodinases (IOP) resulted in,
albeit more subtle, an elongation of the endochondral ossiﬁcation
process with slightly larger sized micromasses and higher levels of
GAGs, COL2 and COL10 for a longer period of time (up to 7 weeks). Also,
the structure of the matrix seems to be denser and better organized
with more cartilage like structures and inhibition of the terminal
maturation of chondrocytes towards bone as reﬂected by smaller
lacunae.
Conclusions: Together our data provide compelling insight in the
detrimental effect of DIO2 over-expression during endochondral
ossiﬁcation. Such insight helps to understand the underlying mecha-
nism by which the OA susceptibility gene DIO2 contributes to the
onset of OA. Our in vitro models are tailored to also explain underlying
mechanisms of other putative OA susceptibility genes such as GDF5
and DOTL1.Figure 1. Alcian Blue staining (A,B), Collagen type 2 IHC (C,D), and Collagen type 10
(E,F) with a 4x magniﬁcation (A,C, and E) and 20x magniﬁcation (B,D, and F) of the
RAAK-247 micromasses transduced with either an eGFP-control or lentiviruses
inducing overexpression of DIO2.
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Purpose: The pathogenesis of osteoarthritis (OA) is believed to involve
the actions of pro-inﬂammatory cytokines such as interleukin 1 (IL-1).
However, there are currently no disease-modifying OA drugs (DMOADs)
available to combat joint degeneration. Amajor limitation to developing
OA therapeutics is the availability of a high-throughput, patient-speciﬁc
screening system. Induced pluripotent stem cells (iPSCs) provide an
attractive cell source for this type of system, as they can be derived from
a skin biopsy and can be expanded indeﬁnitely in culture. Recent work
in our lab has demonstrated that cartilage engineered from iPSCs can
recapitulate many of the properties of native tissue. This approach can
provide virtually unlimited quantities of genetically deﬁned cartilage as
a model system of OA, facilitating the development of high-throughput
screening assays for DMOADs. The goal of this study was to examine the
inﬂuence of IL-1a on iPSC-derived cartilage as an in vitro model of OA
for drug screening.
Methods: A multistep differentiation and puriﬁcation protocol was used
to derive high quality engineered cartilage from murine iPSCs derived
from tail ﬁbroblasts. Cells were ﬁrst differentiated in micromasses using
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driving GFP expression. Puriﬁed cells were expanded and then cultured
as pellets for 3 wks in chondrogenic media containing dexamethasone
and TGF-b3, producing a robust cartilaginous matrix. As a model of OA,
pellets were cultured in standardmediawith IL-1a (0,10, or 100 pg/ml, or
1 ng/ml). After 3 days of culture, the elastic modulus of the pellets was
measured using atomic force microscopy, and the DNA, glycosamino-
glycan (GAG), and collagen contents of the pellets were analyzed bio-
chemically and histologically. Additionally, the media were collected and
analyzed for matrix metalloproteinase (MMP) activity and GAG, nitric
oxide (NO), and prostaglandin E2 (PGE2).
Results: Treatment of iPSC neocartilage with IL-1a produced a clear
degenerative response. MMP release was signiﬁcantly increased in all
treatment groups from a 27-fold increase at 10 pg to a 340-fold increase
at 1 ng/ml (Fig. 1A). The increase in MMPs was associated with a signiﬁ-
cant loss of GAGs from the pellet into themedia. IL-1a at a dose of 1 ng/ml
increased the percentage of total GAG in the media from 19% to 61% (Fig.
1B). Similar trends were apparent for the production of NO and PGE2,
with >6-fold increases at 1 ng/ml IL-1a. Histological analysis conﬁrmed
matrix degradation, with a dramatic decrease in sulfated GAG staining in
the high treatment groups (Fig. 2A). IL-1a treatment at 1 ng/ml also
resulted in a 68% decrease in the compressive modulus (Fig. 2B).
Conclusions: iPSC-derived cartilage displayed a dramatic and dose-
dependent catabolic response to IL-1a, similar to that of native cartilage.
The observed matrix degradation, loss of mechanical properties, andFigure 1. Release of MMPs and GAGs from iPSC-derive cartilage in an in vitro model of
OA. (A) All three IL-1a doses resulted in a signiﬁcant increase in MMP release from iPSC
neocartilage. (B) IL-1 a doses above 100 pg/ml resulted in an increased loss of GAG
from the pellets and into the media. Groups not connected by the same letter as
statistically different with P < 0.05, Mean  SEM.production of inﬂammatory mediators were all consistent with an OA
phenotype. This system also showed the ability to be tailored, as dose
dependent responses of the pellets to IL-1amay be useful for modeling
different stages of the disease or different joint space environments.
This work provides an initial demonstration of the potential of iPSCs for
creating patient-speciﬁc in vitro models of arthritis, which may facili-
tate the discovery of tailored OA therapeutics.
Figure 2. IL-1a induced degeneration of iPSC neocartilage. (A) Safranin-0 staining
conﬁrmed GAG loss from iPSC pellets at high IL-1a doses (positive staining is red, scale
bar ¼ 100 mm). (B) The compressive stiffness of iPSC-derived cartilage signiﬁcantly
decreased following IL-1a treatments above 100 pg/ml. Groups not connected by the
same letter as statistically different with P < 0.05. Mean SEM.
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Purpose: Inﬂammatory mediators such as interleukin-1 (IL-1) promote
catabolic signaling in articular chondrocytes during the pathogenesis of
osteoarthritis (OA) and, additionally, prevent mesenchymal stem cell
(MSC) chondrogenesis. Thus, IL-1 signaling in the OA joint may inhibit
the development or promote the degradation of engineered cartilage as
well as native tissue. The goal of this study was to genetically modify
human MSCs to induce constitutive or doxycycline-inducible expres-
sion of the natural anti-inﬂammatory modulator IL-1 receptor antago-
nist (IL-1Ra) as a cell source for functional cartilage tissue engineering
within an inﬂammatory environment.
Methods: IL-1Ra and eGFP coding sequences were cloned into lentiviral
expression vectors. 293T cells were transfected to produce self-
